| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
SE:SOBI
Swedish Orphan Biovitrum AB
|
May 27, 2026 | BUY |
Strong Buy
-14.7% avg upside
6 analysts
|
$525.00
19.19% Upside
|
· |
|
BNTX
BioNTech SE
|
May 11, 2026 | BUY |
Strong Buy
+50.5% avg upside
26 analysts
|
$140.00
54.00% Upside
|
-2.6% |
|
DE:SRT3
Sartorius
|
Apr 24, 2026 | BUY |
Buy
+26.8% avg upside
17 analysts
|
$250.00
17.42% Upside
|
· |
|
CH:TECN
Tecan Group AG
|
Apr 21, 2026 | BUY |
Buy
+110.9% avg upside
8 analysts
|
$205.00
35.17% Upside
|
· |
|
ATAI
Atai Beckley N.V.
|
Apr 20, 2026 | BUY |
Strong Buy
+230.1% avg upside
16 analysts
|
$14.00
244.86% Upside
|
-18.2% |
|
QGEN
Qiagen
|
Feb 12, 2026 | BUY |
Buy
+14.1% avg upside
23 analysts
|
$57.30
55.05% Upside
|
-35.6% |
|
MRNA
Moderna
|
Jan 22, 2026 | HOLD |
Hold
+6.4% avg upside
38 analysts
|
$32.00
49.91% Downside
|
+23.3% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.